A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Clinical trial NCT05320380 · WITHDRAWN

Trial details

NCT number: NCT05320380
Sponsor: Children's Oncology Group
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Acute Myeloid Leukemia Recurrent B Acute Lymphoblastic Leukemia Recurrent Mixed Phenotype Acute Leukemia Recurrent T Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Refractory B Acute Lymphoblastic Leukemia Refractory Mixed Phenotype Acute Leukemia Refractory T Acute Lymphoblastic Leukemia

Start date: 2023-08-01
Primary completion: 2023-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.